Wednesday, November 23, 2016 12:12:17 PM
With immunotherapies a "healthy gut" is just as important as the therapy itself. One of the reasons that I postulate that a therapy like DCVax-L restores chemotherapy ability to work is that it the modulates the MHC to bring T helper cells back in balance.
Any patient or frankly, anyone who has ever been on any antibiotic needs to get on a probiotic to restore their natural immune response. Antibiotics may actually leave patients susceptible to cancer, specifically relapse. They are learning more each day on how important a healthy gut may actually affect naturally immune system and immunotherapy. All immunotherapy cancer patients should be on Probiotics. Possibly all cancer patients should be on probiotics. I'm certain that UCLA is aware of how proper nutrition affects the immunotherapies.
The company isn't planning to use Cyclophosphamide just because. They are well aware how it affects the gut positively. :)
Some interesting reads to try see what I do about harnessing the gut:
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.778.7750&rep=rep1&type=pdf
https://www.google.com/amp/www.the-scientist.com/%3Farticles.amp/articleNo/45616/title/Microbes-Meet-Cancer/?client=safari
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339017/pdf/nihms662663.pdf
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
